Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SIRPA | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Sirpa (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SIRPA mRNA | CTD | PMID:36331819 | SIRPA | Human | 1,1-dichloroethene | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of SIRPA mRNA | CTD | PMID:26682919 | SIRPA | Human | 1,2-dimethylhydrazine | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SIRPA mRNA | CTD | PMID:22206623 | SIRPA | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Norethindrone Acetate] results in increased expression of SIRPA mRNA more ... | CTD | PMID:20660070 more ... | SIRPA | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SIRPA mRNA] | CTD | PMID:11007951 | SIRPA | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Sirpa (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SIRPA mRNA | CTD | PMID:24680724 and PMID:26377647 | SIRPA | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SIRPA mRNA | CTD | PMID:22298810 and PMID:22574217 | SIRPA | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SIRPA mRNA | CTD | PMID:22298810 and PMID:34747641 | SIRPA | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SIRPA mRNA | CTD | PMID:11007951 | SIRPA | Human | 2,4-dinitrotoluene | affects expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of SIRPA mRNA | CTD | PMID:21346803 | SIRPA | Human | 3-chloropropane-1,2-diol | increases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of SIRPA mRNA | CTD | PMID:28522335 | SIRPA | Human | 4-hydroxyphenyl retinamide | decreases expression | ISO | Sirpa (Mus musculus) | 6480464 | Fenretinide results in decreased expression of SIRPA mRNA | CTD | PMID:28973697 | SIRPA | Human | 4-vinylcyclohexene dioxide | affects expression | ISO | Sirpa (Mus musculus) | 6480464 | 4-vinyl-1-cyclohexene dioxide affects the expression of SIRPA mRNA | CTD | PMID:20829426 | SIRPA | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of SIRPA gene | CTD | PMID:27153756 | SIRPA | Human | Aflatoxin B2 alpha | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of SIRPA intron | CTD | PMID:30157460 | SIRPA | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of SIRPA mRNA | CTD | PMID:15894607 and PMID:33167477 | SIRPA | Human | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of SIRPA mRNA | CTD | PMID:15894607 | SIRPA | Human | ammonium chloride | affects expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of SIRPA mRNA | CTD | PMID:16483693 | SIRPA | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of SIRPA mRNA | CTD | PMID:24449571 | SIRPA | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of SIRPA mRNA | CTD | PMID:33212167 | SIRPA | Human | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of SIRPA promoter | CTD | PMID:23974009 | SIRPA | Human | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of SIRPA mRNA | CTD | PMID:27829220 | SIRPA | Human | arsenous acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SIRPA mRNA | CTD | PMID:15894607 | SIRPA | Human | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of SIRPA mRNA | CTD | PMID:22378314 | SIRPA | Human | benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of SIRPA mRNA | CTD | PMID:19162166 | SIRPA | Human | benzo[a]pyrene | decreases expression | ISO | Sirpa (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of SIRPA mRNA | CTD | PMID:19770486 and PMID:21569818 | SIRPA | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of SIRPA 3' UTR | CTD | PMID:27901495 | SIRPA | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of SIRPA promoter | CTD | PMID:27901495 | SIRPA | Human | benzo[a]pyrene | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SIRPA mRNA | CTD | PMID:22228805 | SIRPA | Human | beta-lapachone | increases expression | EXP | | 6480464 | beta-lapachone results in increased expression of SIRPA mRNA | CTD | PMID:38218311 | SIRPA | Human | bisphenol A | affects expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of SIRPA mRNA | CTD | PMID:25181051 | SIRPA | Human | bisphenol A | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | bisphenol A results in increased expression of SIRPA mRNA | CTD | PMID:33221593 | SIRPA | Human | bisphenol A | increases methylation | ISO | Sirpa (Mus musculus) | 6480464 | bisphenol A results in increased methylation of SIRPA promoter | CTD | PMID:27312807 | SIRPA | Human | cadmium atom | decreases expression | ISO | Sirpa (Mus musculus) | 6480464 | Cadmium results in decreased expression of SIRPA mRNA | CTD | PMID:23358151 | SIRPA | Human | cadmium dichloride | increases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of SIRPA mRNA | CTD | PMID:25993096 | SIRPA | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of SIRPA mRNA | CTD | PMID:38568856 | SIRPA | Human | calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of SIRPA mRNA | CTD | PMID:16002434 | SIRPA | Human | carbon nanotube | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of SIRPA mRNA | CTD | PMID:25554681 | SIRPA | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SIRPA gene] | CTD | PMID:28238834 | SIRPA | Human | choline | multiple interactions | ISO | Sirpa (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SIRPA mRNA | CTD | PMID:20938992 | SIRPA | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of SIRPA mRNA | CTD | PMID:19549813 | SIRPA | Human | cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SIRPA mRNA] | CTD | PMID:11007951 | SIRPA | Human | cyproconazole | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | cyproconazole results in increased expression of SIRPA mRNA | CTD | PMID:22334560 | SIRPA | Human | D-gluconic acid | multiple interactions | ISO | Sirpa (Rattus norvegicus) | 6480464 | [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of SIRPA mRNA | CTD | PMID:16556975 | SIRPA | Human | deoxycholic acid | multiple interactions | ISO | Sirpa (Rattus norvegicus) | 6480464 | [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of SIRPA mRNA | CTD | PMID:16556975 | SIRPA | Human | diarsenic trioxide | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SIRPA mRNA | CTD | PMID:15894607 | SIRPA | Human | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of SIRPA mRNA | CTD | PMID:27829220 | SIRPA | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of SIRPA mRNA | CTD | PMID:37042841 | SIRPA | Human | dibutyl phthalate | decreases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of SIRPA mRNA | CTD | PMID:21266533 | SIRPA | Human | dichlorine | multiple interactions | ISO | Sirpa (Rattus norvegicus) | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of SIRPA mRNA | CTD | PMID:18636392 | SIRPA | Human | elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of SIRPA mRNA | CTD | PMID:19244175 | SIRPA | Human | endosulfan | decreases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of SIRPA mRNA | CTD | PMID:29391264 | SIRPA | Human | epoxiconazole | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | epoxiconazole results in increased expression of SIRPA mRNA | CTD | PMID:22334560 | SIRPA | Human | ethanol | affects splicing | ISO | Sirpa (Mus musculus) | 6480464 | Ethanol affects the splicing of SIRPA mRNA | CTD | PMID:30319688 | SIRPA | Human | fipronil | increases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | fipronil results in increased expression of SIRPA mRNA | CTD | PMID:34044035 | SIRPA | Human | folic acid | multiple interactions | ISO | Sirpa (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SIRPA mRNA | CTD | PMID:20938992 | SIRPA | Human | fonofos | increases methylation | EXP | | 6480464 | Fonofos results in increased methylation of SIRPA promoter | CTD | PMID:22847954 | SIRPA | Human | gentamycin | decreases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of SIRPA mRNA | CTD | PMID:33387578 | SIRPA | Human | glafenine | increases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | Glafenine results in increased expression of SIRPA mRNA | CTD | PMID:24136188 | SIRPA | Human | isotretinoin | increases expression | EXP | | 6480464 | Isotretinoin results in increased expression of SIRPA mRNA | CTD | PMID:20436886 | SIRPA | Human | L-methionine | multiple interactions | ISO | Sirpa (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SIRPA mRNA | CTD | PMID:20938992 | SIRPA | Human | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of SIRPA mRNA | CTD | PMID:28988120 | SIRPA | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SIRPA protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]] more ... | CTD | PMID:12805067 | SIRPA | Human | LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SIRPA protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]] | CTD | PMID:12805067 | SIRPA | Human | menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of SIRPA mRNA | CTD | PMID:20044591 | SIRPA | Human | methotrexate | increases expression | EXP | | 6480464 | Methotrexate results in increased expression of SIRPA mRNA | CTD | PMID:24449571 | SIRPA | Human | methoxychlor | affects expression | ISO | Sirpa (Mus musculus) | 6480464 | Methoxychlor affects the expression of SIRPA mRNA | CTD | PMID:20829426 | SIRPA | Human | methoxychlor | affects methylation | ISO | Sirpa (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of SIRPA gene | CTD | PMID:35440735 | SIRPA | Human | Muraglitazar | decreases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | muraglitazar results in decreased expression of SIRPA mRNA | CTD | PMID:21515302 | SIRPA | Human | N-methyl-4-phenylpyridinium | multiple interactions | ISO | Sirpa (Mus musculus) | 6480464 | [CD47 protein binds to SIRPA protein] inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein] more ... | CTD | PMID:28268219 | SIRPA | Human | N-nitrosomorpholine | increases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | N-nitrosomorpholine results in increased expression of SIRPA mRNA | CTD | PMID:19716841 | SIRPA | Human | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of SIRPA mRNA | CTD | PMID:25583101 | SIRPA | Human | nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of SIRPA mRNA | CTD | PMID:22714537 | SIRPA | Human | nitrofen | decreases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | nitrofen results in decreased expression of SIRPA mRNA | CTD | PMID:26720608 | SIRPA | Human | NSC 23766 | multiple interactions | ISO | Sirpa (Mus musculus) | 6480464 | NSC 23766 inhibits the reaction [[CD47 protein binds to SIRPA protein] inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein]] more ... | CTD | PMID:28268219 | SIRPA | Human | ozone | multiple interactions | ISO | Sirpa (Rattus norvegicus) | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of SIRPA mRNA | CTD | PMID:18636392 | SIRPA | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SIRPA mRNA | CTD | PMID:21420995 | SIRPA | Human | paracetamol | decreases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of SIRPA mRNA | CTD | PMID:32479839 and PMID:33387578 | SIRPA | Human | paraquat | increases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | Paraquat results in increased expression of SIRPA mRNA | CTD | PMID:17077588 and PMID:18198484 | SIRPA | Human | parathion | increases methylation | EXP | | 6480464 | Parathion results in increased methylation of SIRPA promoter | CTD | PMID:22847954 | SIRPA | Human | perfluorohexanesulfonic acid | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of SIRPA mRNA | CTD | PMID:37995155 | SIRPA | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Sirpa (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SIRPA mRNA | CTD | PMID:36331819 | SIRPA | Human | pirinixic acid | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | pirinixic acid results in increased expression of SIRPA mRNA | CTD | PMID:23811191 | SIRPA | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of SIRPA mRNA | CTD | PMID:22714537 | SIRPA | Human | progesterone | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of SIRPA mRNA | CTD | PMID:20660070 | SIRPA | Human | propiconazole | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | propiconazole results in increased expression of SIRPA mRNA | CTD | PMID:22334560 | SIRPA | Human | selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of SIRPA mRNA | CTD | PMID:19244175 | SIRPA | Human | silicon dioxide | increases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | Silicon Dioxide results in increased expression of SIRPA mRNA | CTD | PMID:32721576 | SIRPA | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of SIRPA mRNA | CTD | PMID:22714537 | SIRPA | Human | sodium arsenite | decreases expression | ISO | Sirpa (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of SIRPA mRNA | CTD | PMID:37682722 | SIRPA | Human | sodium fluoride | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of SIRPA mRNA | CTD | PMID:27862939 | SIRPA | Human | terbufos | increases methylation | EXP | | 6480464 | terbufos results in increased methylation of SIRPA promoter | CTD | PMID:22847954 | SIRPA | Human | Tesaglitazar | decreases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | tesaglitazar results in decreased expression of SIRPA mRNA | CTD | PMID:21515302 | SIRPA | Human | tetrachloroethene | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | Tetrachloroethylene results in increased expression of SIRPA mRNA | CTD | PMID:28973375 | SIRPA | Human | tetrachloromethane | affects expression | ISO | Sirpa (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of SIRPA mRNA | CTD | PMID:17484886 | SIRPA | Human | tetrachloromethane | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of SIRPA mRNA | CTD | PMID:29987408 | SIRPA | Human | thimerosal | decreases expression | EXP | | 6480464 | Thimerosal results in decreased expression of SIRPA mRNA | CTD | PMID:27188386 | SIRPA | Human | thioacetamide | increases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of SIRPA mRNA | CTD | PMID:23411599 and PMID:34492290 | SIRPA | Human | titanium dioxide | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | titanium dioxide results in increased expression of SIRPA mRNA | CTD | PMID:23557971 | SIRPA | Human | titanium dioxide | increases methylation | ISO | Sirpa (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of SIRPA gene | CTD | PMID:35295148 | SIRPA | Human | titanium dioxide | decreases expression | ISO | Sirpa (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of SIRPA mRNA | CTD | PMID:29264374 | SIRPA | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of SIRPA mRNA | CTD | PMID:24935251 | SIRPA | Human | trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of SIRPA mRNA | CTD | PMID:28542535 | SIRPA | Human | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of SIRPA mRNA | CTD | PMID:30510588 | SIRPA | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of SIRPA mRNA | CTD | PMID:37042841 | SIRPA | Human | triptonide | increases expression | ISO | Sirpa (Mus musculus) | 6480464 | triptonide results in increased expression of SIRPA mRNA | CTD | PMID:33045310 | SIRPA | Human | tris(2-butoxyethyl) phosphate | affects expression | EXP | | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of SIRPA mRNA | CTD | PMID:29024780 | SIRPA | Human | troglitazone | decreases expression | ISO | Sirpa (Rattus norvegicus) | 6480464 | troglitazone results in decreased expression of SIRPA mRNA | CTD | PMID:21515302 | SIRPA | Human | tungsten | decreases expression | ISO | Sirpa (Mus musculus) | 6480464 | Tungsten results in decreased expression of SIRPA mRNA | CTD | PMID:30912803 | SIRPA | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of SIRPA gene | CTD | PMID:29154799 | SIRPA | Human | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of SIRPA mRNA | CTD | PMID:27188386 | SIRPA | Human | wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [SIRPA protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]] | CTD | PMID:12805067 | |